Li X - Search Results

1

Advancements and perspectives of RBX2 as a molecular hallmark in cancer.

Tao Y, Dai L, Liang W, Li X, Lyu Y, Li J, Li Z, Shi Z, Liang X, Zhou S, Fu X, Hu W, Wang X. Tao Y, et al. Among authors: li j, li z, li x. Gene. 2024 Jan 20;892:147864. doi: 10.1016/j.gene.2023.147864. Epub 2023 Oct 10. Gene. 2024. PMID: 37820940 Free article. Review.

2

Systematic characterization and biological functions of non-coding RNAs in glioblastoma.

Dai L, Liang W, Shi Z, Li X, Zhou S, Hu W, Yang Z, Wang X. Dai L, et al. Among authors: li x. Cell Prolif. 2023 Mar;56(3):e13375. doi: 10.1111/cpr.13375. Epub 2022 Dec 1. Cell Prolif. 2023. PMID: 36457281 Free PMC article. Review.

3

Dai L, Xiao J, Li X, Tao Y, Zhou P, Lyu L, Shi Z, Liang X, Jia Z, Jiang S. Dai L, et al. Among authors: li x. J Gene Med. 2024 May;26(5):e3685. doi: 10.1002/jgm.3685. J Gene Med. 2024. PMID: 38686653

4

LINC00645 inhibits renal cell carcinoma progression by interacting with HNRNPA2B1 to regulate the ROCK1 mRNA stability.

Li H, Han X, Song L, Li X, Zhang L, Jin Z, Zhang Y, Wang T, Huang Z, Jia Z, Yang J. Li H, et al. Among authors: li x. Gene. 2024 May 5;905:148232. doi: 10.1016/j.gene.2024.148232. Epub 2024 Feb 1. Gene. 2024. PMID: 38309317

5

Small molecular inhibitors for KRAS-mutant cancers.

Wu X, Song W, Cheng C, Liu Z, Li X, Cui Y, Gao Y, Li D. Wu X, et al. Among authors: li d, li x. Front Immunol. 2023 Aug 18;14:1223433. doi: 10.3389/fimmu.2023.1223433. eCollection 2023. Front Immunol. 2023. PMID: 37662925 Free PMC article. Review.

6

Effects of p450 Polymorphisms on the Clinical Outcomes of Gefitinib Treatment in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer.

Fan R, Zhao J, Wang B, Li X, Guan Y, Ren P, Sun R, Zhang L, Guo Y. Fan R, et al. Among authors: li x. Genet Test Mol Biomarkers. 2022 Dec;26(12):582-588. doi: 10.1089/gtmb.2022.0070. Genet Test Mol Biomarkers. 2022. PMID: 36577124

7

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Dai X, Chen W, Qiao Y, Chen X, Chen Y, Zhang K, Zhang Q, Duan X, Li X, Zhao J, Tian F, Liu K, Dong Z, Lu J. Dai X, et al. Among authors: li x. Cancer Lett. 2024 Feb 1;582:216596. doi: 10.1016/j.canlet.2023.216596. Epub 2023 Dec 13. Cancer Lett. 2024. PMID: 38101610

8

Corrigendum to "A SERS bioassay based on vancomycin-modified PEI-interlayered nanocomposite and aptamer-functionalized SERS tags for synchronous detection of Acinetobacter baumannii and Klebsiella pneumonia" [Food Chemistry 423 (2023) 136242].

Effah CY, Ding L, Tan L, He S, Li X, Yuan H, Li Y, Liu S, Sun T, Wu Y. Effah CY, et al. Among authors: li y, li x. Food Chem. 2023 Nov 30;427:136704. doi: 10.1016/j.foodchem.2023.136704. Epub 2023 Jun 21. Food Chem. 2023. PMID: 37393126 No abstract available.

9

Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops.

Zhou T, Li X, Yang J, Xia H, Liu Q, He J, Zhang J. Zhou T, et al. Among authors: li x. J Ocul Pharmacol Ther. 2023 Apr;39(3):229-234. doi: 10.1089/jop.2022.0146. Epub 2023 Feb 13. J Ocul Pharmacol Ther. 2023. PMID: 36779981

10

A SERS bioassay based on vancomycin-modified PEI-interlayered nanocomposite and aptamer-functionalized SERS tags for synchronous detection of Acinetobacter baumannii and Klebsiella pneumoniae.

Effah CY, Ding L, Tan L, He S, Li X, Yuan H, Li Y, Liu S, Sun T, Wu Y. Effah CY, et al. Among authors: li y, li x. Food Chem. 2023 Oct 15;423:136242. doi: 10.1016/j.foodchem.2023.136242. Epub 2023 May 8. Food Chem. 2023. PMID: 37196408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168,299 results

Search Page